PubRank

G Pantaleo

Author PubWeight™ 134.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001 7.90
2 Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996 7.59
3 Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med 1995 4.65
4 Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med 1983 4.47
5 Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis 1997 3.35
6 A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 1990 2.93
7 Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994 2.92
8 Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis 1996 2.84
9 Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996 2.61
10 Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995 2.42
11 Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. Proc Natl Acad Sci U S A 1988 2.30
12 Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. J Exp Med 1983 2.16
13 NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991 2.15
14 Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001 2.05
15 Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000 1.99
16 Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex. J Exp Med 1985 1.92
17 Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc Natl Acad Sci U S A 2000 1.73
18 Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS 1999 1.73
19 A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). J Exp Med 1988 1.71
20 Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000 1.69
21 Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection. J Infect Dis 2000 1.66
22 CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet 1998 1.62
23 Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci U S A 1993 1.54
24 Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nat Med 1998 1.50
25 Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates. Eur J Immunol 1987 1.49
26 Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation. Proc Natl Acad Sci U S A 1987 1.47
27 The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS 2001 1.46
28 Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest 1997 1.46
29 Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A 1996 1.44
30 Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A 1996 1.39
31 Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis 2016 1.39
32 Selection and characterization of monoclonal antibodies to the idiotype-like structure of an interleukin-2-producing human leukemia T-cell line. Int J Cancer 1985 1.38
33 Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans. Immunol Rev 1989 1.33
34 Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen-dependent and antigen-independent pathways of human T cell activation. Eur J Immunol 1986 1.33
35 Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function. J Exp Med 1984 1.29
36 CD3+ WT31- peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the alpha/beta heterodimer. Eur J Immunol 1987 1.23
37 Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation. J Exp Med 1987 1.19
38 Anticlonotypic monoclonal antibodies induce proliferation of clonotype-positive T cells in peripheral blood human T lymphocytes. Evidence for a phenotypic (T4/T8) heterogeneity of the clonotype-positive proliferating cells. J Exp Med 1985 1.09
39 CCR2 polymorphism and HIV disease. Swiss HIV Cohort. Nat Med 1998 1.07
40 Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci U S A 1994 1.07
41 Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. J Immunol 1991 1.04
42 Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes. J Immunol 1991 1.03
43 Surface markers of cloned human T cells with helper or suppressor activity on pokeweed mitogen-driven B cell differentiation. Eur J Immunol 1982 1.01
44 Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones. Eur J Immunol 1984 0.99
45 Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc Natl Acad Sci U S A 1995 0.99
46 Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti-CD4 monoclonal antibody. Eur J Immunol 1988 0.98
47 Intercellular adhesion molecules (ICAM)-1 ICAM-2 and ICAM-3 function as counter-receptors for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation. Eur J Immunol 1994 0.98
48 Signal transducing mechanisms involved in human T cell activation via surface T44 molecules. Comparison with signals transduced via the T cell receptor complex. Eur J Immunol 1986 0.98
49 Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures. Eur J Immunol 1984 0.97
50 Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count. AIDS 2000 0.96
51 Different types of effector cells involved in non-mhc-restricted cytolytic activity. Ann Inst Pasteur Immunol 1988 0.96
52 Positive and negative regulation of cellular immune responses in physiologic conditions and diseases. Clin Dev Immunol 2012 0.95
53 Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir. Ther Drug Monit 2001 0.94
54 The moving target: mechanisms of HIV persistence during primary infection. Immunol Today 1999 0.94
55 Immunopathogenesis of human immunodeficiency virus infection. Clin Infect Dis 1993 0.92
56 Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy. AIDS 2000 0.91
57 Unraveling the strands of HIV's web. Nat Med 1999 0.91
58 Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1995 0.91
59 Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope. Eur J Immunol 1999 0.90
60 HIV-1 infection in the lymphoid organs. AIDS 1993 0.90
61 Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood 2000 0.89
62 Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. J Infect Dis 1996 0.88
63 gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individuals: an immunoelectron microscopic study. AIDS 1997 0.88
64 Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope. Vasc Med 2003 0.87
65 Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay. Med Microbiol Immunol 2012 0.87
66 Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies. Springer Semin Immunopathol 1997 0.86
67 Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis 2015 0.86
68 Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy. J Biol Regul Homeost Agents 1998 0.85
69 Immunopathogenesis of HIV infection. AIDS Res Hum Retroviruses 1998 0.85
70 Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis 2014 0.85
71 Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort. Eur J Immunol 1997 0.85
72 Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infect Dis 2015 0.84
73 Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA. J Clin Invest 2000 0.84
74 Involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions: effect of anti-T11 monoclonal antibody on functional capabilities of alloreactive T cell clones. Eur J Immunol 1985 0.84
75 Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants. Vaccine 2001 0.84
76 Immunology of HIV infection. Res Immunol 1998 0.83
77 Surface markers of human lymphokine-activated killer cells and their precursors. Analysis at the population and clonal level. Int J Cancer 1987 0.83
78 High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infect Dis 2011 0.83
79 Recent advances in the phenotypic and functional analysis of human T lymphocytes. Semin Hematol 1984 0.82
80 The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism. J Virol 1993 0.81
81 Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys. J Infect Dis 1997 0.80
82 Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy. Clin Exp Immunol 2008 0.80
83 Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals. Infection 2008 0.80
84 Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals. Res Immunol 1995 0.79
85 Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort Study. AIDS 1999 0.78
86 Identification of a novel 45-kDa cell surface molecule involved in activation of the human Jurkat T cell line. Eur J Immunol 1987 0.78
87 Response: HIV Quasispecies and Resampling. Science 1996 0.78
88 Potential role of immune modulation in the effective long-term control of HIV-1 infection. J Biol Regul Homeost Agents 2002 0.78
89 Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infect Dis 2015 0.78
90 Nano-structured gold catalysts supported on CeO2 and CeO2-Al2O3 for NOx reduction by CO: effect of catalyst pretreatment and feed composition. J Nanosci Nanotechnol 2008 0.78
91 Adjunctive effect of chlorhexidine antiseptics in mechanical periodontal treatment: first results of a preliminary case series. Int J Dent Hyg 2012 0.77
92 Comparison of phorbol-12-myristate-13-acetate and dioctanoyl-sn-glycerol in the activation of EL4/6.1 thymoma cells. J Cell Physiol 1989 0.77
93 T cell regeneration in HIV-infected subjects under highly active antiretroviral therapy (review). Int J Mol Med 1999 0.77
94 Cyclosporin A in combination with HAART in primary HIV-1 infection. J Biol Regul Homeost Agents 2000 0.76
95 Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy. J Infect Dis 1998 0.76
96 Activated cytotoxic lymphocytes in lymph nodes from human immunodeficiency virus (HIV) 1-infected patients: a light and electronmicroscopic study. Histopathology 1997 0.75
97 The multi-faceted personality of HIV. Nat Med 1997 0.75
98 Sequence analysis of the novel HLA-B35 (B*3576) allele in an African individual. Tissue Antigens 2007 0.75
99 Recent progresses in the phenotypic and functional characterization of human cytolytic T lymphocytes. Ric Clin Lab 1985 0.75
100 Therapeutic perspectives in HIV-1 infection from recent advances in HIV-1 pathogenesis: it is time to move on. J Biol Regul Homeost Agents 1999 0.75
101 Involvement of T3 and T8 molecules in human T cell receptor function. Anti-T3 or anti-T8 antibodies do not block the antigen-dependent activation of a subset of alloreactive cytolytic T cell precursors. Eur J Immunol 1985 0.75
102 Time-resolved X-ray powder diffraction on a three-way catalyst at the GILDA beamline. J Synchrotron Radiat 2003 0.75
103 Analysis of virologic and immunologic events in HIV infection. Pathobiology 1998 0.75
104 Surface markers of resting and activated human T cells. Functional implications and experimental limits. Springer Semin Immunopathol 1982 0.75
105 Response: Correlates of Protective Viruses Damaging to HIV Infection. Science 1996 0.75
106 Identification of a functional T-cell population by the use of surface markers: present limitations and new strategies. Ann Immunol (Paris) 1983 0.75
107 Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions. Behring Inst Mitt 1985 0.75
108 Stimulation of antibody response in the gastrointestinal mucosa of immunodeficient mice by oral treatment with bacterial antigens. An immunoperoxidase study. Int J Immunopharmacol 1989 0.75
109 New mechanisms of viral persistence in primary human immunodeficiency virus (HIV) infection. J Biol Regul Homeost Agents 1998 0.75
110 Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. Elife 2017 0.75
111 New concepts in the immunopathogenesis of HIV infection. J Biol Regul Homeost Agents 1996 0.75
112 Expression of a wide T cell receptor V beta repertoire in human T lymphocytes derived in vitro from embryonic liver cell precursors. Eur J Immunol 1994 0.75
113 Phenotypic and functional heterogeneity of human peripheral blood T lymphocytes producing colony stimulating factor. A clonal and precursor frequency analysis. J Immunol 1985 0.75
114 Difficulties and new strategies in the identification of functional T cell populations in humans. Monogr Allergy 1983 0.75